Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Other solid neoplasm 1

Conditions

Refractory Solid Tumors 1

Interventions

pembrolizumab 2fludarabine 2apatinib 2Interleukin-2 2Cyclophosphamide 2spartalizumab 1phosphorylethanolamine 1olaparib 1liposomal doxorubicin 1ivarmacitinib 1camrelizumab 1anlotinib 1Valproic Acid 1Topotecan 1Talc 1Pharmaceutical Services 1Injections 1Hydralazine 1Cisplatin 1Cerebral Decortication 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Valproic Acid × Other solid neoplasm × Clear all
NCT00404508 2006-11-28

A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

National Institute of Cancerología

Phase 2 Completed
15 enrolled
Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡